Erlotinib Induced Fatal Interstitial Lung Disease in a Patient with Metastatic Non-Small Cell Lung Cancer: Case Report and Review of Literature

Erlotinib is one of the most widely used tyrosine kinase inhibitor targeting human epidermal growth factor receptor. Since its introduction, it has revolutionized the treatment of advanced non-small cell lung cancer. Skin rashes and diarrhea are the most often reported side effects of erlotinib howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangla, Ankit, Agarwal, Nikki, Carmel, Chou, Lad, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064300/
https://www.ncbi.nlm.nih.gov/pubmed/27746884
http://dx.doi.org/10.4081/rt.2016.6410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064300/
https://www.ncbi.nlm.nih.gov/pubmed/27746884
http://dx.doi.org/10.4081/rt.2016.6410

Ejemplares similares